Alerus Financial Na Abb Vie Inc. Transaction History

Alerus Financial Na

$1.25 Billion
Q4 2024

A detailed history of Alerus Financial Na transactions in Abb Vie Inc. stock. As of the latest transaction made, Alerus Financial Na holds 48,087 shares of ABBV stock, worth $9.43 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

48,087

Previous 47,465 1.31%

Holding current value

$9.43 Million

Previous $9.37 Million 8.83%

% of portfolio

0.68%

Previous 0.72%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$164.99 - $203.87 $102,623 - $126,807	622 Added 1.31%	48,087 $8.55 Million
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $85,196 - $103,651	-520 Reduced 1.08%	47,465 $9.37 Million
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $184,045 - $214,923	1,189 Added 2.54%	47,985 $8.23 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $11,826 - $13,475	74 Added 0.16%	46,796 $8.52 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $51,875 - $58,423	377 Added 0.81%	46,722 $7.24 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $116,356 - $134,700	-871 Reduced 1.84%	46,345 $6.91 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $797,312 - $992,203	6,017 Added 14.6%	47,216 $6.36 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $814,443 - $937,953	5,632 Added 15.83%	41,199 $6.57 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $83,954 - $100,683	-607 Reduced 1.68%	35,567 $5.75 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $107,636 - $123,451	-802 Reduced 2.17%	36,174 $4.86 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $258,175 - $328,224	-1,876 Reduced 4.83%	36,976 $5.66 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $3.25 Million - $4.04 Million	24,651 Added 173.59%	38,852 $6.3 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $1.53 Million - $1.93 Million	14,201 New	14,201 $1.92 Million
Q1 2020 May 12, 2020	SELL	$64.5 - $97.79 $229,426 - $347,839	-3,557 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $30,734 - $36,951	-488 Reduced 12.06%	3,557 $269,000
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $26,937 - $34,431	-410 Reduced 9.2%	4,045 $294,000
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $23,913 - $28,144	310 Added 7.48%	4,455 $359,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $23,472 - $26,093	-264 Reduced 5.99%	4,145 $392,000
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $1.51 Million - $1.79 Million	-16,831 Reduced 79.24%	4,409 $408,000
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $1.26 Million - $1.68 Million	-13,660 Reduced 39.14%	21,240 $2.01 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $3.13 Million - $3.43 Million	34,900	34,900 $3.38 Million

Others Institutions Holding ABBV

# of Institutions

4,212

Shares Held

1.29B

Call Options Held

16.8M

Put Options Held

14.8M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $347B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alerus Financial Na, based on Form 13F filings with the SEC.

News

Stay updated on Alerus Financial Na with notifications on news.

Account

Alerus Financial Na Abb Vie Inc. Transaction History